as on January 21, 2026 at 8:39 pm IST
Day's Low
Day's High
0.71%
Downside
0.71%
Upside
52 Week's Low
52 Week's High
50.88%
Downside
33.21%
Upside
Check Whitehawk Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$137.1M
EPS (TTM)
-0.25
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-13.82%
Compare market cap, revenue, PE, and other key metrics of Whitehawk Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $137.1M | NA | NA | -108.58% | |
| BUY | $47.4B | 113.21% | 1237.91 | 1.36% | |
| BUY | $113.2B | 85.25% | 31.06 | 31.35% | |
| NA | $37.4B | NA | 663.12 | 1.38% | |
| BUY | $77.7B | 37.03% | 17.57 | 32.13% |
Search interest for Whitehawk Therapeutics Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:33% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -52.61M → -17.74M (in $), with an average increase of 196.5% per quarter
Price Rise
![]()
In the last 1 month, WHWK stock has moved up by 11.7%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 52.8% return, outperforming this stock by 58.1%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.5% return, outperforming this stock by 103.2%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 7.23M → 7.14M (in $), with an average decrease of 1.3% per quarter
| Organisation | Whitehawk Therapeutics Inc |
| Headquarters | 2 Headquarters Plaza, Morristown, NJ, United States, 07960 |
| CEO | Dr. David J. Lennon Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. David Dornan Ph.D. | Chief Scientific Officer |
Mr. Stephen M. Rodin J.D. | Senior VP of Legal & General Counsel |
Dr. Margaret Han Dugan M.D. | Chief Medical Officer |
Dr. David J. Lennon Ph.D. | President, CEO & Director |
Dr. Neil P. Desai Ph.D. | Founder & Director |
Mr. Scott M. Giacobello CPA | CFO, Treasurer, Investor Relations & Corporate Communications |
Mr. Bryan Ball | Chief Technical Operations Officer |
Whitehawk Therapeutics Inc share price today is $2.83 as on . Whitehawk Therapeutics Inc share today touched a day high of $2.85 and a low of $2.81.
Whitehawk Therapeutics Inc share touched a 52 week high of $3.77 on and a 52 week low of $1.39 on . Whitehawk Therapeutics Inc stock price today i.e. is trending at $2.83,which is 24.93% down from its 52 week high and 103.60% up from its 52 week low.
Whitehawk Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Whitehawk Therapeutics Inc (WHWK) shares with as little as ₹91.673 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹916.73 in Whitehawk Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Whitehawk Therapeutics Inc share’s latest price of $2.83 as on January 21, 2026 at 8:39 pm IST, you will get 3.5336 shares of Whitehawk Therapeutics Inc. Learn more about
fractional shares .